BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9519830)

  • 1. Role of the DR2 repeat array in the regulation of the ICP34.5 gene promoter of herpes simplex virus type 1 during productive infection.
    Martin DW; Weber PC
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():517-23. PubMed ID: 9519830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of anisomorphic DNA conformations in the negative regulation of a herpes simplex virus type 1 promoter.
    Sarisky RT; Weber PC
    Virology; 1994 Nov; 204(2):569-79. PubMed ID: 7941324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection.
    Rivera-Gonzalez R; Imbalzano AN; Gu B; Deluca NA
    Virology; 1994 Aug; 202(2):550-64. PubMed ID: 8030221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.
    Goins WF; Sternberg LR; Croen KD; Krause PR; Hendricks RL; Fink DJ; Straus SE; Levine M; Glorioso JC
    J Virol; 1994 Apr; 68(4):2239-52. PubMed ID: 8139009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional modules important for activated expression of early genes of herpes simplex virus type 1 are clustered upstream of the TATA box.
    Pande NT; Petroski MD; Wagner EK
    Virology; 1998 Jun; 246(1):145-57. PubMed ID: 9657002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSV-2 ICP34.5 protein modulates herpes simplex virus glycoprotein processing.
    Chatterjee S; Wang JW; Cismowski MJ; Bower JR; Rosenthal KS
    Arch Virol; 2009; 154(4):661-3. PubMed ID: 19267180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a promoter-specific transactivation domain in the herpes simplex virus regulatory protein ICP4.
    Xiao W; Pizer LI; Wilcox KW
    J Virol; 1997 Mar; 71(3):1757-65. PubMed ID: 9032304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurovirulent factor ICP34.5 uniquely expressed in the herpes simplex virus type 1 Delta gamma 1 34.5 mutant 1716.
    Holman HA; MacLean AR
    J Neurovirol; 2008 Jan; 14(1):28-40. PubMed ID: 18300073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of regulatory functions of the HSV-1 immediate-early protein ICP22.
    Prod'hon C; Machuca I; Berthomme H; Epstein A; Jacquemont B
    Virology; 1996 Dec; 226(2):393-402. PubMed ID: 8955059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A haploid HSV-1 genome platform for vector development: testing of the tetracycline-responsive switch shows interference by infected cell protein 0.
    Khalique H; López Marco J; Lim F
    J Gene Med; 2016 Oct; 18(10):302-311. PubMed ID: 27672733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
    Lieu PT; Wagner EK
    Virology; 2000 Jun; 272(1):191-203. PubMed ID: 10873762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clustering of Sp1 sites near the promoter region of ICP34.5 in herpes simplex virus type 1.
    Chung IK; Soisson SM; Muller MT
    J Biochem; 1995 Jan; 117(1):19-22. PubMed ID: 7775388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response.
    Pasieka TJ; Baas T; Carter VS; Proll SC; Katze MG; Leib DA
    J Virol; 2006 Aug; 80(15):7600-12. PubMed ID: 16840339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of neighboring gene expression by the herpes simplex virus type 1 thymidine kinase gene.
    Cook WJ; Wobbe KK; Böni J; Coen DM
    Virology; 1996 Apr; 218(1):193-203. PubMed ID: 8615022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dominant mutant form of the herpes simplex virus ICP8 protein decreases viral late gene transcription.
    Chen YM; Knipe DM
    Virology; 1996 Jul; 221(2):281-90. PubMed ID: 8661438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudorabies virus early protein 0 transactivates the viral gene promoters.
    Watanabe S; Ono E; Shimizu Y; Kida H
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2881-5. PubMed ID: 7595399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-dependent structural variants of herpes simplex virus type 1 ICP34.5 determine viral plaque size, efficiency of glycoprotein processing, and viral release and neuroinvasive disease potential.
    Mao H; Rosenthal KS
    J Virol; 2003 Mar; 77(6):3409-17. PubMed ID: 12610116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters.
    Summers BC; Leib DA
    J Virol; 2002 Jul; 76(14):7020-9. PubMed ID: 12072502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of factors influencing kinetics of herpes simplex virus transcription utilizing recombinant virus.
    Wagner EK; Petroski MD; Pande NT; Lieu PT; Rice M
    Methods; 1998 Sep; 16(1):105-16. PubMed ID: 9774520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.